ARTICLE | Company News

Management tracks

July 16, 2015 1:19 AM UTC

Antibiotics developer Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH) named Jacques Dumas CSO. He was CSO at Idenix Pharmaceuticals Inc., which Merck & Co. Inc. (NYSE:MRK) acquired.

Antibacterial company Entasis Therapeutics Inc. (Waltham, Mass.) named Robin Isaacs CMO. He was VP and therapeutic area head of vaccine clinical research at Merck. ...